Beacon Dermatology Inc /ID# 250336

Calgary, Alberta T3A 2N1

0 studies enrolling now · 1 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis — Completed